AGIO:NASDAQ
Agios Pharmaceuticals Inc
$29.68
arrow_downward
-0.70%(-0.21) 1D
$29.68
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 18, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
$29.57
High
$30.48
Low
$29.22
Mkt. cap
1.78B
Avg. vol.
1.21M
Volume
0.00
52-wk high
$44.07
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
Open
$29.57
High
$30.48
Low
$29.22
Mkt. cap
1.78B
Avg. vol.
1.21M
Volume
0.00
52-wk high
$44.07
52-wk low
$22.24
EPS
-$6.32
Beta
0.66
Shares outstanding
59.81M
No. of employees
540
News stories
From web sources and news partners
TradingView
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
Chattanooga Times Free Press
·
1 hour ago
A fifth straight drop for the S&P 500 drags Wall Street to its longest losing streak since June
BigGo Finance
·
2 hours ago
UBS Sets S&P 500 Target of 8,200 by End-2027, Implying Roughly 12% Upside, But Cuts Rating to Neutral
FOREX.com
·
2 hours ago
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc